IBDEI0V9 ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,41054,1,4,0)
 ;;=4^L93.1
 ;;^UTILITY(U,$J,358.3,41054,2)
 ;;=^5009468
 ;;^UTILITY(U,$J,358.3,41055,0)
 ;;=M32.0^^119^1760^19
 ;;^UTILITY(U,$J,358.3,41055,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41055,1,3,0)
 ;;=3^Lupus,Erythematosus,Drug-Induced Systemic
 ;;^UTILITY(U,$J,358.3,41055,1,4,0)
 ;;=4^M32.0
 ;;^UTILITY(U,$J,358.3,41055,2)
 ;;=^5011752
 ;;^UTILITY(U,$J,358.3,41056,0)
 ;;=M32.10^^119^1760^22
 ;;^UTILITY(U,$J,358.3,41056,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41056,1,3,0)
 ;;=3^Lupus,Erythematosus,Systemic
 ;;^UTILITY(U,$J,358.3,41056,1,4,0)
 ;;=4^M32.10
 ;;^UTILITY(U,$J,358.3,41056,2)
 ;;=^5011753
 ;;^UTILITY(U,$J,358.3,41057,0)
 ;;=M32.19^^119^1760^24
 ;;^UTILITY(U,$J,358.3,41057,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41057,1,3,0)
 ;;=3^Lupus,Erythematosus,Systemic,Skin Involvmnt
 ;;^UTILITY(U,$J,358.3,41057,1,4,0)
 ;;=4^M32.19
 ;;^UTILITY(U,$J,358.3,41057,2)
 ;;=^5011759
 ;;^UTILITY(U,$J,358.3,41058,0)
 ;;=M32.9^^119^1760^23
 ;;^UTILITY(U,$J,358.3,41058,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41058,1,3,0)
 ;;=3^Lupus,Erythematosus,Systemic w/o Organ Involvmnt
 ;;^UTILITY(U,$J,358.3,41058,1,4,0)
 ;;=4^M32.9
 ;;^UTILITY(U,$J,358.3,41058,2)
 ;;=^5011761
 ;;^UTILITY(U,$J,358.3,41059,0)
 ;;=E88.1^^119^1760^17
 ;;^UTILITY(U,$J,358.3,41059,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41059,1,3,0)
 ;;=3^Lipodystrophy NOS
 ;;^UTILITY(U,$J,358.3,41059,1,4,0)
 ;;=4^E88.1
 ;;^UTILITY(U,$J,358.3,41059,2)
 ;;=^5003028
 ;;^UTILITY(U,$J,358.3,41060,0)
 ;;=C85.19^^119^1760^2
 ;;^UTILITY(U,$J,358.3,41060,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41060,1,3,0)
 ;;=3^B-Cell Lymphoma,Unspec,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,41060,1,4,0)
 ;;=4^C85.19
 ;;^UTILITY(U,$J,358.3,41060,2)
 ;;=^5001710
 ;;^UTILITY(U,$J,358.3,41061,0)
 ;;=C85.13^^119^1760^5
 ;;^UTILITY(U,$J,358.3,41061,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41061,1,3,0)
 ;;=3^B-Cell Lymphoma,Unspec,Intra-Abdominal Lymph Nodes
 ;;^UTILITY(U,$J,358.3,41061,1,4,0)
 ;;=4^C85.13
 ;;^UTILITY(U,$J,358.3,41061,2)
 ;;=^5001704
 ;;^UTILITY(U,$J,358.3,41062,0)
 ;;=C85.16^^119^1760^6
 ;;^UTILITY(U,$J,358.3,41062,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41062,1,3,0)
 ;;=3^B-Cell Lymphoma,Unspec,Intrapelvic Lymph Nodes
 ;;^UTILITY(U,$J,358.3,41062,1,4,0)
 ;;=4^C85.16
 ;;^UTILITY(U,$J,358.3,41062,2)
 ;;=^5001707
 ;;^UTILITY(U,$J,358.3,41063,0)
 ;;=C85.12^^119^1760^7
 ;;^UTILITY(U,$J,358.3,41063,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41063,1,3,0)
 ;;=3^B-Cell Lymphoma,Unspec,Intrathoracic Lymph Nodes
 ;;^UTILITY(U,$J,358.3,41063,1,4,0)
 ;;=4^C85.12
 ;;^UTILITY(U,$J,358.3,41063,2)
 ;;=^5001703
 ;;^UTILITY(U,$J,358.3,41064,0)
 ;;=C85.14^^119^1760^1
 ;;^UTILITY(U,$J,358.3,41064,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41064,1,3,0)
 ;;=3^B-Cell Lymphoma,Unspec,Axilla/Upper Limb Lymph Nodes
 ;;^UTILITY(U,$J,358.3,41064,1,4,0)
 ;;=4^C85.14
 ;;^UTILITY(U,$J,358.3,41064,2)
 ;;=^5001705
 ;;^UTILITY(U,$J,358.3,41065,0)
 ;;=C85.11^^119^1760^3
 ;;^UTILITY(U,$J,358.3,41065,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41065,1,3,0)
 ;;=3^B-Cell Lymphoma,Unspec,Head/Face/Neck Lymph Nodes
 ;;^UTILITY(U,$J,358.3,41065,1,4,0)
 ;;=4^C85.11
 ;;^UTILITY(U,$J,358.3,41065,2)
 ;;=^5001702
 ;;^UTILITY(U,$J,358.3,41066,0)
 ;;=C85.15^^119^1760^4
 ;;^UTILITY(U,$J,358.3,41066,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41066,1,3,0)
 ;;=3^B-Cell Lymphoma,Unspec,Inguinal Region/LE Lymph Nodes
 ;;^UTILITY(U,$J,358.3,41066,1,4,0)
 ;;=4^C85.15
 ;;^UTILITY(U,$J,358.3,41066,2)
 ;;=^5001706
 ;;^UTILITY(U,$J,358.3,41067,0)
 ;;=C85.18^^119^1760^8
 ;;^UTILITY(U,$J,358.3,41067,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41067,1,3,0)
 ;;=3^B-Cell Lymphoma,Unspec,Multiple Site Lymph Nodes
 ;;^UTILITY(U,$J,358.3,41067,1,4,0)
 ;;=4^C85.18
 ;;^UTILITY(U,$J,358.3,41067,2)
 ;;=^5001709
 ;;^UTILITY(U,$J,358.3,41068,0)
 ;;=C85.17^^119^1760^9
 ;;^UTILITY(U,$J,358.3,41068,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41068,1,3,0)
 ;;=3^B-Cell Lymphoma,Unspec,Spleen
 ;;^UTILITY(U,$J,358.3,41068,1,4,0)
 ;;=4^C85.17
 ;;^UTILITY(U,$J,358.3,41068,2)
 ;;=^5001708
 ;;^UTILITY(U,$J,358.3,41069,0)
 ;;=C85.10^^119^1760^10
 ;;^UTILITY(U,$J,358.3,41069,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41069,1,3,0)
 ;;=3^B-Cell Lymphoma,Unspec,Unspec Site
 ;;^UTILITY(U,$J,358.3,41069,1,4,0)
 ;;=4^C85.10
 ;;^UTILITY(U,$J,358.3,41069,2)
 ;;=^5001701
 ;;^UTILITY(U,$J,358.3,41070,0)
 ;;=L60.1^^119^1761^2
 ;;^UTILITY(U,$J,358.3,41070,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41070,1,3,0)
 ;;=3^Onycholysis
 ;;^UTILITY(U,$J,358.3,41070,1,4,0)
 ;;=4^L60.1
 ;;^UTILITY(U,$J,358.3,41070,2)
 ;;=^186837
 ;;^UTILITY(U,$J,358.3,41071,0)
 ;;=L60.2^^119^1761^1
 ;;^UTILITY(U,$J,358.3,41071,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41071,1,3,0)
 ;;=3^Onychogryphosis
 ;;^UTILITY(U,$J,358.3,41071,1,4,0)
 ;;=4^L60.2
 ;;^UTILITY(U,$J,358.3,41071,2)
 ;;=^5009235
 ;;^UTILITY(U,$J,358.3,41072,0)
 ;;=B35.1^^119^1761^3
 ;;^UTILITY(U,$J,358.3,41072,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41072,1,3,0)
 ;;=3^Onychomycosis
 ;;^UTILITY(U,$J,358.3,41072,1,4,0)
 ;;=4^B35.1
 ;;^UTILITY(U,$J,358.3,41072,2)
 ;;=^119748
 ;;^UTILITY(U,$J,358.3,41073,0)
 ;;=L50.8^^119^1762^4
 ;;^UTILITY(U,$J,358.3,41073,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41073,1,3,0)
 ;;=3^Urticaria,Other Spec
 ;;^UTILITY(U,$J,358.3,41073,1,4,0)
 ;;=4^L50.8
 ;;^UTILITY(U,$J,358.3,41073,2)
 ;;=^5009203
 ;;^UTILITY(U,$J,358.3,41074,0)
 ;;=L50.0^^119^1762^2
 ;;^UTILITY(U,$J,358.3,41074,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41074,1,3,0)
 ;;=3^Urticaria,Allergic
 ;;^UTILITY(U,$J,358.3,41074,1,4,0)
 ;;=4^L50.0
 ;;^UTILITY(U,$J,358.3,41074,2)
 ;;=^5009200
 ;;^UTILITY(U,$J,358.3,41075,0)
 ;;=L50.6^^119^1762^3
 ;;^UTILITY(U,$J,358.3,41075,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41075,1,3,0)
 ;;=3^Urticaria,Contact
 ;;^UTILITY(U,$J,358.3,41075,1,4,0)
 ;;=4^L50.6
 ;;^UTILITY(U,$J,358.3,41075,2)
 ;;=^5009202
 ;;^UTILITY(U,$J,358.3,41076,0)
 ;;=L50.2^^119^1762^1
 ;;^UTILITY(U,$J,358.3,41076,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41076,1,3,0)
 ;;=3^Urticaria d/t Cold/Heat
 ;;^UTILITY(U,$J,358.3,41076,1,4,0)
 ;;=4^L50.2
 ;;^UTILITY(U,$J,358.3,41076,2)
 ;;=^271938
 ;;^UTILITY(U,$J,358.3,41077,0)
 ;;=L56.3^^119^1762^5
 ;;^UTILITY(U,$J,358.3,41077,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41077,1,3,0)
 ;;=3^Urticaria,Solar
 ;;^UTILITY(U,$J,358.3,41077,1,4,0)
 ;;=4^L56.3
 ;;^UTILITY(U,$J,358.3,41077,2)
 ;;=^5009217
 ;;^UTILITY(U,$J,358.3,41078,0)
 ;;=B02.8^^119^1763^1
 ;;^UTILITY(U,$J,358.3,41078,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41078,1,3,0)
 ;;=3^Zoster w/ Other Complications
 ;;^UTILITY(U,$J,358.3,41078,1,4,0)
 ;;=4^B02.8
 ;;^UTILITY(U,$J,358.3,41078,2)
 ;;=^5000500
 ;;^UTILITY(U,$J,358.3,41079,0)
 ;;=B02.9^^119^1763^2
 ;;^UTILITY(U,$J,358.3,41079,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41079,1,3,0)
 ;;=3^Zoster w/o Complications
 ;;^UTILITY(U,$J,358.3,41079,1,4,0)
 ;;=4^B02.9
 ;;^UTILITY(U,$J,358.3,41079,2)
 ;;=^5000501
 ;;^UTILITY(U,$J,358.3,41080,0)
 ;;=Q3014^^120^1764^5^^^^1
 ;;^UTILITY(U,$J,358.3,41080,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,41080,1,2,0)
 ;;=2^Q3014
 ;;^UTILITY(U,$J,358.3,41080,1,3,0)
 ;;=3^TELEHEALTH FACILITY FEE
 ;;^UTILITY(U,$J,358.3,41081,0)
 ;;=92227^^120^1764^3^^^^1
 ;;^UTILITY(U,$J,358.3,41081,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,41081,1,2,0)
 ;;=2^92227
 ;;^UTILITY(U,$J,358.3,41081,1,3,0)
 ;;=3^REMOTE DX RETINAL IMAGING
 ;;^UTILITY(U,$J,358.3,41082,0)
 ;;=92228^^120^1764^4^^^^1
 ;;^UTILITY(U,$J,358.3,41082,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,41082,1,2,0)
 ;;=2^92228
 ;;^UTILITY(U,$J,358.3,41082,1,3,0)
 ;;=3^REMOTE IMAGING-RETINAL MGMT
 ;;^UTILITY(U,$J,358.3,41083,0)
 ;;=92250^^120^1764^1^^^^1
 ;;^UTILITY(U,$J,358.3,41083,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,41083,1,2,0)
 ;;=2^92250
 ;;^UTILITY(U,$J,358.3,41083,1,3,0)
 ;;=3^FUNDUS PHOTO W/ INTERP & RPT
 ;;^UTILITY(U,$J,358.3,41084,0)
 ;;=T1014^^120^1764^6^^^^1
 ;;^UTILITY(U,$J,358.3,41084,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,41084,1,2,0)
 ;;=2^T1014
 ;;^UTILITY(U,$J,358.3,41084,1,3,0)
 ;;=3^TELEHEALTH TRANSMIT, PER MIN
 ;;^UTILITY(U,$J,358.3,41085,0)
 ;;=3072F^^120^1764^2^^^^1
 ;;^UTILITY(U,$J,358.3,41085,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,41085,1,2,0)
 ;;=2^3072F
 ;;^UTILITY(U,$J,358.3,41085,1,3,0)
 ;;=3^LOW RISK FOR RETINOPATHY
 ;;^UTILITY(U,$J,358.3,41086,0)
 ;;=H54.0^^121^1765^8
 ;;^UTILITY(U,$J,358.3,41086,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41086,1,3,0)
 ;;=3^Blindness,Both Eyes
 ;;^UTILITY(U,$J,358.3,41086,1,4,0)
 ;;=4^H54.0
 ;;^UTILITY(U,$J,358.3,41086,2)
 ;;=^5006357
 ;;^UTILITY(U,$J,358.3,41087,0)
 ;;=H54.12^^121^1765^3
 ;;^UTILITY(U,$J,358.3,41087,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41087,1,3,0)
 ;;=3^Blindness-Lt Eye/Low Vision-Rt Eye
 ;;^UTILITY(U,$J,358.3,41087,1,4,0)
 ;;=4^H54.12
 ;;^UTILITY(U,$J,358.3,41087,2)
 ;;=^5006360
 ;;^UTILITY(U,$J,358.3,41088,0)
 ;;=H54.11^^121^1765^2
 ;;^UTILITY(U,$J,358.3,41088,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41088,1,3,0)
 ;;=3^Blindness-Rt Eye/Low Vision-Lt Eye
 ;;^UTILITY(U,$J,358.3,41088,1,4,0)
 ;;=4^H54.11
 ;;^UTILITY(U,$J,358.3,41088,2)
 ;;=^5006359
 ;;^UTILITY(U,$J,358.3,41089,0)
 ;;=H54.2^^121^1765^4
 ;;^UTILITY(U,$J,358.3,41089,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41089,1,3,0)
 ;;=3^Low Vision,Both Eyes
 ;;^UTILITY(U,$J,358.3,41089,1,4,0)
 ;;=4^H54.2
 ;;^UTILITY(U,$J,358.3,41089,2)
 ;;=^5006361
 ;;^UTILITY(U,$J,358.3,41090,0)
 ;;=H54.3^^121^1765^10
 ;;^UTILITY(U,$J,358.3,41090,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41090,1,3,0)
 ;;=3^Visual Loss,Both Eyes,Unqualified
 ;;^UTILITY(U,$J,358.3,41090,1,4,0)
 ;;=4^H54.3
 ;;^UTILITY(U,$J,358.3,41090,2)
 ;;=^268886
 ;;^UTILITY(U,$J,358.3,41091,0)
 ;;=H54.41^^121^1765^5
 ;;^UTILITY(U,$J,358.3,41091,1,0)
 ;;=^358.31IA^4^2
